Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 50 citing articles:

Faecalibacterium: a bacterial genus with promising human health applications
Rebeca Martín, David Ríos-Covián, Eugénie Huillet, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 4
Open Access | Times Cited: 178
Biomarkers of response to PD-1 pathway blockade
Hanxiao Li, P. Anton van der Merwe, Shivan Sivakumar
British Journal of Cancer (2022) Vol. 126, Iss. 12, pp. 1663-1675
Open Access | Times Cited: 126
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Connor Campbell, Mrunmayee Kandalgaonkar, Rachel M. Golonka, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 116
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Mengwei Zhang, Jinkai Liu, Qiang Xia
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 49
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Gut microbiota-mediated immunomodulation in tumor
Xinyi Liu, Yanjie Chen, Si Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 68
Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors
Marius Bredon, Camille Danne, Hang‐Phuong Pham, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Effect of a Novel Food Rich in Miraculin on the Intestinal Microbiome of Malnourished Patients with Cancer and Dysgeusia
Julio Plaza‐Díaz, Marco Brandimonte-Hernández, Bricia López‐Plaza, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 246-246
Open Access | Times Cited: 1
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
Min-Woo Chung, Moon‐Ju Kim, Eun Jeong Won, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 42, pp. 7340-7349
Open Access | Times Cited: 55
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4824-4824
Open Access | Times Cited: 46
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 21, pp. 2251-2281
Open Access | Times Cited: 35
Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation
Ze Xiang, Jian Wu, Jiarui Li, et al.
Engineering (2023) Vol. 29, pp. 59-72
Open Access | Times Cited: 17
Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies
Giada Marroncini, Laura Naldi, Serena Martinelli, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1398-1398
Open Access | Times Cited: 7
Predicting cancer immunotherapy response from gut microbiomes using machine learning models
Hai Liang, Jay‐Hyun Jo, Zhiwei Zhang, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 876-889
Open Access | Times Cited: 28
Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
Ludovico Abenavoli, Michele Montori, Gianluca Svegliati‐Baroni, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1427-1427
Open Access | Times Cited: 13
Checkpoint inhibitor responses can be regulated by the gut microbiota – A systematic review
M. Zeriouh, Hans Raskov, Lasse Kvich, et al.
Neoplasia (2023) Vol. 43, pp. 100923-100923
Open Access | Times Cited: 13
Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection
Mohammed El‐Mowafy, Abdelaziz Elgaml, Mohamed El‐Mesery, et al.
Biology (2021) Vol. 10, Iss. 1, pp. 55-55
Open Access | Times Cited: 30
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4631-4631
Open Access | Times Cited: 20
The Interplay between Medical Plants and Gut Microbiota in Cancer
Santino Caserta, Claudia Genovese, Nicola Cicero, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3327-3327
Open Access | Times Cited: 11
HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies
Carmelo Laface, E Lauricella, Girolamo Ranieri, et al.
Onco (2025) Vol. 5, Iss. 1, pp. 9-9
Open Access
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota
Alberto Vogrig, Marta Dentoni, Irene Florean, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top